tiprankstipranks
Tissue Regenix Group PLC (GB:TRX)
LSE:TRX
UK Market

Tissue Regenix (TRX) Income Statement

Compare
13 Followers

Tissue Regenix Income Statement

Last quarter (Q4 2023), Tissue Regenix's total revenue was $12.08M, an increase of 77.67% from the same quarter last year. In Q4, Tissue Regenix's net income was $-643.23K. See Tissue Regenix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 29.49M$ 19.87M$ 14.36M$ 12.83M$ 13.03M
Gross Profit
$ 14.04M$ 9.14M$ 5.63M$ 5.13M$ 4.97M
Operating Expenses
$ 14.43M$ 10.75M$ 8.61M$ 9.25M$ 12.15M
Depreciation and Amortization
$ 977.00K$ 921.43K$ 793.28K$ 762.00K$ 1.05M
EBITDA
$ 446.00K$ -690.87K$ -2.19M$ -9.03M$ -6.13M
Operating Income
$ -394.00K$ -1.61M$ -2.98M$ -4.12M$ -7.18M
Other Income/Expenses
$ -948.66K$ -285.86K$ 639.19K$ -6.12M$ 1.78M
Pretax Income
$ -1.34M$ -2.30M$ -3.74M$ -10.24M$ -7.66M
Net Income
$ -1.71M$ -2.19M$ -3.48M$ -9.71M$ -6.97M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.02$ -0.03$ -0.05$ -0.22$ -0.60
Diluted EPS
$ -0.02$ -0.03$ -0.05$ -0.22$ -0.60
Weighted Average Shares Outstanding
70.43M 70.35M 70.33M 44.48M 11.72M
Weighted Average Shares Outstanding (Diluted)
70.43M 70.35M 70.33M 44.48M 11.72M
Currency in USD

Tissue Regenix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis